Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Five-year boostability after single-dose versus 2-dose intramuscular rabies pre-exposure prophylaxis
NL-OMON51662Phase 4Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2022
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Rabies vaccine in rabies (2 arms), sponsored by Leiden University Medical Center. Started Nov 2022; status: recruiting.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NL-OMON51662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51662.